Colin Brenan is a Co-founder of HiFiBiO Inc. and the Chief Commercial Officer of HiFiBiO Therapeutics. He is a serial entrepreneur with more than 30 years of experience in scientific research, project management, product development, strategic marketing, and financing of early-stage life science companies.
Previously, Dr. Brenan was Managing Director of the Monsanto-Atlas Seed Fund Alliance at Atlas Venture. Prior to Atlas, he was Director of Strategic Relationships for the Partners HealthCare Center for Integration of Medicine and Innovative Technology (CIMIT). Earlier in his career, he was the Founder, Chief Technology Officer and Senior Vice President of Business Development at BioTrove Inc., a life science tools and consumables company spun-out from the Massachusetts Institute of Technology (MIT) and acquired by Life Technologies Inc. (NASDAQ:LIFE); and a Founder of Biocius Inc., a drug development instrument and service provider spun-out from BioTrove and acquired by Agilent Inc. (NYSE:A).
Dr. Brenan received his BSc (Honors Physics), MEng (Electrical), and PhD (Biomedical Engineering) from McGill University (Montreal, Canada) and completed a NSERC post-doctoral fellowship at MIT.